At a glance
- Originator Roche
- Class Antiretrovirals; Small molecules
- Mechanism of Action Human immunodeficiency virus tat gene product inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 07 Aug 1999 Discontinued-Preclinical for HIV infections treatment in Switzerland (Unknown route)
- 14 Jul 1999 No-Development-Reported for HIV infections treatment in Switzerland (Unknown route)
- 17 Nov 1994 Preclinical development for HIV infections treatment in Switzerland (Unknown route)